Page last updated: 2024-08-24

aripiprazole and ru 66647

aripiprazole has been researched along with ru 66647 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gagne, JJ; Maclure, M; Schneeweiss, S; Wang, SV1
Hashiguchi, M; Imai, S; Maruyama, J; Mochizuki, M; Shimizu, M; Uehara, K1

Other Studies

2 other study(ies) available for aripiprazole and ru 66647

ArticleYear
"First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.
    American journal of epidemiology, 2014, Sep-15, Volume: 180, Issue:6

    Topics: Anti-Bacterial Agents; Antipsychotic Agents; Aripiprazole; Bias; Case-Control Studies; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Databases, Pharmaceutical; Humans; Isoxazoles; Ketolides; Marketing; Medicaid; Pharmacoepidemiology; Piperazines; Product Surveillance, Postmarketing; Quinolones; Sulfonamides; United States

2014
Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions.
    PloS one, 2015, Volume: 10, Issue:12

    Topics: Adverse Drug Reaction Reporting Systems; Aripiprazole; Chemical and Drug Induced Liver Injury; Data Mining; Databases, Factual; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Exenatide; Humans; Hypercalcemia; Ketolides; Pancreatitis; Peptides; Rhabdomyolysis; Rosuvastatin Calcium; Suicide; Teriparatide; Time Factors; United States; United States Food and Drug Administration; Varenicline; Venoms

2015